Infographic: Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE)

Eye (Lond). 2023 Dec 20. doi: 10.1038/s41433-023-02867-4. Online ahead of print.
No abstract available